Abstract The incidence of osteoporotic fractures is rising in western societies, partly due to unknown reasons. Persistent organochlorine compounds (POC) have in animal studies impaired the normal bone metabolism and resulted in increased bone fragility, which might have health implications for POC-exposed human populations. The aim of the present study was to assess whether a high dietary intake of POC through fatty fish from the Baltic may result in decreased bone mineral density (BMD) or disturbances in biochemical markers of bone metabolism. From a study base of fishermen and fishermen's wives from the Swedish east coast who are considerably more POC-exposed than the general Swedish population, 196 men (median age 59 years) and 184 women (median age 62 years) participated in an examination of their forearm BMD, using dual energy xray absorptiometry (DXA). Further, POC exposure was assessed by analysis of lipid-adjusted serum levels of 2,2',4,4',5,5'-hexachlorobiphenyl (CB-153) and 1,1-dichloro-2,2-bis(p-chlorophenyl)-ethylene (p,p'-DDE). Cadmium in urine (U-Cd) was also analyzed. Biochemical markers in serum of osteoblastic (osteocalcin) and osteoclastic (CrossLaps) functions were measured. Adjustment for potential confounders was made by employing multiple regression analyses. Univariate analyses showed significant negative associations between CB-153 concentrations and BMD, but after adjustment for age and body mass index, these associations did not remain. None of the POC exposure variables were associated with CrossLaps or osteocalcin.
Introduction
Persistent organochlorine compounds (POCs), such as polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), and pesticides such as dichlorodiphenyl trichloroethane (DDT), have been released into the environment, mainly since the Second World War. POCs have been detected in human blood, adipose tissue, and breast milk worldwide, but accumulate in particular in high-ranking predators of the aquatic food chain.
It has been shown in animal studies that at least dioxin-like POC may impair normal bone metabolism and result in increased bone fragility [1] [2] [3] [4] . Some sparse animal data indicate both impaired bone mineralization [1] and reduced collagen content and serum osteocalcin levels [2] .
High accidental exposure to a POC, hexachlorobenzene, resulted in severe human osteoporosis [5] , and infants exposed in utero to high concentrations of PCB and PCDF developed irregular calcification of their skull bones [6] . Thus, high exposure levels to POCs may impair normal bone metabolism in humans. The pertinent question is whether POC levels more relevant for different groups in the general population might be harmful for the human skeleton.
The mechanisms for POC-related impairment of normal bone metabolism are not well known. Bone is a target tissue for estrogens, and estrogen deficiency associated with menopause is the cause of the most rapid phase of bone loss in women [7] . Moreover, estrogens seem to be involved in maintaining the male skeleton [8] . Some POC compounds have estrogenic, some have antiestrogenic, and some have androgenic properties [9] [10] [11] . Thus, the net effect in vivo on hormonal homeostasis of dietary exposure to a mixture of a large number of POCs can be difficult to predict [12] . Moreover, a cross-talk between the Ah-receptor and the estrogen receptor pathways has also been postulated [13] . Finally, some PCBs are inhibitors of aromatase activity in vitro [14] , and coplanar PCBs have been found to directly affect the expression of steroidogenic enzyme genes [15] . Besides their mechanisms of action mediated by sex steroid hormones' receptors [16] [17] [18] , PCBs were reported to inhibit estrogen sulfotransferase, the enzyme responsible for inhibiting estrogen metabolism [19, 20] , and to alter GnRH gene expression, also indicating a hypothalamic level for endocrine disruption by these environmental toxicants [21] .
Thus, dioxins and other POCs act as endocrine disruptors and modulate the homeostasis of estrogens and other steroid hormone systems, at either the receptor level by altering metabolism, or by affecting serum transport [22] , but the effect in vivo on bone metabolism is not easily predicted.
Recently it has been proposed that many of the toxic actions of dioxins and dioxin-like compounds are caused by their action to trigger severe stress responses by the affected cells, such as by stimulation of cellular production of cytokines [23] . Whether this mechanism might be of relevance for POC effects on bone metabolism is presently not known.
There has been an increase in osteoporotic fractures in western societies during the last decades, even when accounting for age [24] [25] [26] . Sweden is one of the countries with the highest incidence of osteoporotic fractures [27] . The reasons for this increase are not well known, but changes in environmental factors might be important [24, 28] . It is well known that high cadmium (Cd) exposure will damage the kidneys, followed by severe osteoporosis and osteomalacia as a secondary effect [29, 30] . Recent European studies have suggested that Cd can induce osteoporosis at much lower exposure levels than previously reported [31] [32] [33] . A high dietary intake of POCs might act as another potential environmental risk factor for deteriorated bone quality in humans. Three small epidemiological studies show conflicting results with respect to whether dietary POC exposure decreases bone mineral density (BMD) [34] [35] [36] .
In Sweden, consumption of fatty fish from the Baltic Sea, off the Swedish east coast, is the single major exposure source for POCs [37, 38] , and cohorts of Swedish professional fishermen and their families have been found to constitute excellent study bases for epidemiological evaluations of human health effects of POC. Swedish east coast fishermen had three-times higher serum levels of POC than both fishermen living at the west coast of Sweden and the general Swedish population [38] . Moreover, fishermen's wives had twice the fish consumption as control subjects [39] , and fishermen's wives from the east coast had higher plasma levels of PCB than women from the general population [40] .
Initially we analyzed the fracture incidence in the study base, which consisted of fishermen and fishermen's wives from the Swedish east and west coasts [41, 42] . As a complement, we have now also performed a cross-sectional study of BMD and biochemical markers of bone metabolism within the east coast cohorts. We have used 2,2',4,4',5,5'-hexachlorobiphenyl (CB-153) as a biomarker for POC exposure because it correlates very well with both total PCB concentration in plasma and serum (r ‡0.9) [43, 44] , with the PCB derived dioxin-like effect (r=0.91) [44] , and with the total POCderived dioxin-like effect (r=0.74) [45] . Another relevant exposure biomarker is the antiandrogenic compound 1,1-dichloro-2,2-bis(p-chlorophenyl)-ethylene (p,p'-DDE), which is the major metabolite of DDT. p,p'-DDE is still present in relatively high serum concentrations in men consuming fatty fish from the Baltic Sea [46] .
The aim of the study was to assess whether a high dietary intake of POC through fatty fish from the Baltic may result in decreased BMD or disturbances in biochemical markers of bone metabolism.
Subjects and methods

Study population and interview
Previously established cohorts of professional fishermen and their wives from the Swedish east coast [38, 39] were linked to the National Cause-of-Death Register at Statistics Sweden, and vital status was determined as of 31 December 1999 by linkage to the Swedish Population Register. A postal questionnaire, primarily aimed to assess the fracture incidence but also including a question about whether the subjects were interested in participating in a BMD study, was sent in the year 2000 to 1,500 fishermen and 1,291 fishermen's wives who were born between 1920 and 1954 and were living in Sweden and still alive on 31 December 1999 [42] . There were 813 men (54%) and 779 women (77%) who responded to the questionnaire. Of them, 510 men and 596 women agreed to participate in the BMD study. We excluded 177 of the 596 women from participation because they had not yet reached their menopause. Another five women and eight men were excluded because a linkage with the population register showed that they had died since responding to the questionnaire. The remaining 502 men and 414 women were invited by letter to participate in the study, and 351 men and 300 women accepted the invitation. We had a preset goal of examining 200 men and 200 women, we and consecutively contacted subjects by phone for agreements until enough subjects were recruited. During the telephone recruitment, 75 men and 45 women were found to have changed their minds about participating, and another 12 men and 12 women did not show up at their agreed-upon appointments. We examined, however, 208 men and 206 women.
Of these 414 examined subjects, we had to exclude five men and seven women because of incomplete blood samples or BMD investigations, five women who still not were in menopause, one woman with Cushing's syndrome, and four women and two men who had been on long-time treatment with oral steroids for rheumatoid arthritis. Moreover, we afterward excluded five men and five women with high parathyroid hormone (PTH values), indicating hyperparathyroidism or vitamin D deficiency. Thus, the final data set comprised 196 men and 184 women.
The examinations were made at different locations close to where the subjects were living, all along the Swedish east coast. The participants were interviewed using a standardized questionnaire. They were asked about factors that potentially might affect the BMD, such as age at menarche and menopause, current hormone replacement therapy (HRT), history of osteoporotic fractures, heredity of fracture, physical activity at work (current and at 25 and 35 years of age), smoking habits, and current alcohol consumption. We measured current weight with an HL 120 Light Industrial Scale (Avery Berkel) and height using a standardized measuring rod. Descriptive data are given in Table 1 .
The study was performed in accordance with the Declaration of Helsinki and approved by the Lund University Ethics Committee. All participants provided written informed consent.
Nonparticipants
Five-hundred and two fishermen were invited to participate, but 306 of them were not included in the final data set. Based on data from the original questionnaire, which was sent in the year 2000, the nonparticipants had similar age distribution (median age in the year 2000 was 58 years, range 45-80) as the participants (median 56, range . In addition, the body mass index (BMI) distributions were also very similar among the nonparticipants (median 26.5 kg/m 2 , range 17.1-39.9) and the participants (median 27.2, range 20.5-38.5). Of the male nonparticipants, 1.3% had a history of osteoporotic fracture after 50 years of age, and 78% were been smokers at some point in their lives. The corresponding figures among the participants were 1.5% and 81%, respectively.
Among the 230 female nonparticipants, the median age in year 2000 was 61 years (range , and the median BMI was 26.2 kg/m 2 (range 19.7-38.2). The corresponding figures among the 184 participants were 59 years (range 45-79) and 26.0 kg/m 2 (range 18.7-39.6), respectively. Of the female nonparticipants, 6.5% had a history of osteoporotic fracture after 50 years of age, and 54% had been smokers at some point in their lives. The corresponding figures among the participants were 7.6% and 52%, respectively.
Blood and urine sampling
Venous blood samples (125 ml) were drawn between 8:00 and 10:00 a.m., after 12 hr of fasting, into sterile Vacutainer glass tubes (BD Vacutainer, Plymouth, UK). Serum was separated by centrifugation (4,000 rpm, 10 min) and transferred to glass bottles and special tubes. Spot urine samples were collected in the morning in paper cups and immediately transferred into two screw-capped 12-ml polypropylene test tubes (Sarstedt, Nu¨mbrecht, Germany) that were initially kept in a refrigerator. Concentrated nitric acid was added to achieve a 2% acid concentration. Paper cups and test tubes were pretested for their Cd content and were found to be Cd-free (i.e., below detection limit). All serum and urine samples were stored at )80 o C until analysis.
Bone mineral density measurement A dual-energy x-ray absorptiometry (DXA) was used. The Osteometer DTX-200 estimated the bone mineral content (BMC, in g) and BMD (g/cm 2 ) in the distal section of the forearm (radius and ulna). The participants were placed in an upright position with the dominant forearm placed in a container during the examination. The x-ray source was located on one side of the container, and the detector was located on the other side. The internal variation was checked by daily calibration using a phantom, with a known BMC.
Determination of CB-153 and p, p'-DDE in serum
The serum levels of CB-153 and p, p'-DDE were determined as previously described [47, 48] . Briefly, the CB-153 and p, p'-DDE were extracted from the serum by solid phase extraction (Isolute ENV+; IST, Hengoed, UK) using on-column degradation of the lipids and analysis by gas chromatography mass spectrometry. 13 C 12 -labeled CB-153 and 13 C 12 -labeled p, p'-DDE were used as internal standards. The relative standard deviations, calculated from samples analyzed in duplicate on different days, was 8% at 0.8 ng/ml (n=76) and 7% at 2.7 ng/ml for CB-153, and 7% at 1.3 ng/ml and 9% at 7.0 ng/ml for p, p'-DDE. The quantification limits were 0.05 ng/ml for CB-153 and 0.1 ng/ml for p, p'-DDE. Determination of serum lipids by enzymatic methods Serum concentrations of triglycerides and cholesterol were determined by enzymatic methods using reagents from Roche Diagnostics (Mannheim, Germany). The interassay coefficients of variation (CV) for cholesterol and triglyceride determinations were 2-4%. The average molecular weights of triglycerides were assumed to be 807. For cholesterol we used an average molecular weight of 571, assuming that the proportion of free and esterified cholesterol in plasma was 1:2. Based on a paper by Rylander et al., the total lipid concentration in serum (g/l) was calculated by the following equations [49] :
Men: Total = 0.96+1.28·(triglycerides + cholesterols)
Women: Total = 1.13+1.31·(triglycerides + cholesterols)
Determination of cadmium in urine
The concentration of Cd in urine was determined by inductively coupled plasma-mass spectrometry (Thermo X7, Thermo Elemental, Winsford, UK). Interference corrections were made for 114 Cd for the spectral overlap of molybdenoxide and tin. The limit of detection, calculated as three times the standard deviation (SD) for the blank, was 0.03 lg/l. All urine samples were prepared in duplicate, and the method imprecision, calculated as the CV for duplicate measurements, was 5.3%. The analytical accuracy was checked against reference material. The results obtained were 4.4±0.02lg/l (mean±SD), n=20, vs. recommended 4.9 lg/l (Seronorm; batch FE1114, Nycomed, Oslo, Norway) and 0.75±0.03 lg/l (mean±SD), n=26, vs. certified 0.79 lgl (batch D-03-01, Interlaboratory Comparison Programe, Centre de Toxicologie du Quebec; Canada). To correct for differences in urinary flow rate, the Cd concentration in the urine samples was adjusted for the creatinine content, determined enzymatically according to Mazzachi et al. [50] .
Analyses of biochemical markers of bone metabolism CrossLaps (CTX) in serum was determined with the Elecsys b-CrossLaps immunoassay (Roche Diagnostics, Mannheim, Germany). This method specifically recognizes C-terminal fragments of type I collagen containing the b-isomerized octapeptide EKAHD-b-GGR. Total CV for this method is 6.6 and 4.6% at 260 and 2,600 ng/ l, respectively. The upper normal limit of CTX in plasma for men is 710 ng/l (50-70 years) and 840 ng/l (>70 years), whereas the upper normal limit for postmenopausal women is 730 ng/l.
Osteocalcin in serum was determined with the Elecsys N-MID Osteocalcin immunoassay (Roche Diagnostics), which measures the sum of intact osteocalcin (aa and the large N-terminal fragment (aa 1-43). The method has a total CV of 2.3% and 2.4% at 18 and 175 lg/l and a reference interval of 10-43 lg/l.
Parathyroid hormone (PTH) in serum was determined with the Elecsys PTH immunoassay (Roche Diagnostics), which employs two monoclonal antibodies, one reacting with the N-terminal part of the molecule (aa 1-37) and another directed at the C-terminal part (aa 38-84). The total CV of this method is 4.4% and 4.1% at 7.0 and 80 pmol/l, respectively. The reference interval is 1.6-6.9 pmol/l. PTH in serum was used to screen for possible hyperparathyroidism and vitamin D deficiency, but it was not used as an outcome variable because we had no a priori hypothesis that an effect of POC on bone metabolism would involve PTH.
Statistics
Separate analyses were performed for men and women. The effects of the exposure variables CB-153 and p,p'-DDE, respectively, on BMD, osteocalcin, and CTX were evaluated by linear regression models. The exposure variables were treated as continuous variables (untransformed and log transformed) as well as categorized into four equally sized groups. The categorized variables were entered as dummy variables in the models. Because of the high correlation between CB-153 and p,p'-DDE (women r=0.68; men r=0.64), these variables were not included in the models simultaneously. As potential confounders we considered the variables presented in Table 1 . We also evaluated the effect of Cd in urine (continuous and categorized into three equally sized groups) on the outcome variables. If the potential confounders in univariate analyses showed any association (p<0.15) with the outcome variables, they were included in the models, one at a time, together with the exposure variable. The confounders were kept in the model if the effect estimate (i.e., the univariate effect of the exposure variable on the outcome variable) was changed more than 15%. However, in the tables the crude estimates are also shown. Model assumptions were checked by means of residual analysis.
Results
The distributions of the POC exposure variables and the outcome variables are given in Table 2 . The univariate analyses showed significant negative associations between CB-153 concentrations and BMD in both men and women (Tables 3 and 4 ). An increase of the CB-153 concentrations in serum of 100 ng/g lipid corresponded to a decrease in BMD of 3.8 mg/cm 2 (95% CI )7.4, )0.1, Fig. 1 and Table 3 ) among the men and a decrease of 10 mg/cm 2 (95% CI )18, )3.5, Fig. 2 and Table 4 ) among the women. However, after adjustment for age and BMI, none of these significant associations remained. Among the women the pattern was similar regarding the association between p,p'-DDE and BMD, whereas there were no such associations at all among the men. Neither log transformation nor categorization of the exposure variables changed these patterns.
None of the POC exposure variables was associated with CTX or osteocalcin.
There were no significant associations between U-Cd and BMD or any of the biochemical markers (all p>0.10) for either men or women. Inclusion of age or smoking habits in multivariate models did not change these results.
Discussion
The main result of the present study was that there were no remaining associations between the POC exposure markers (CB-153 and p,p'-DDE) and BMD when adjustments for age and BMI had been made. The univariate associations between the exposure markers and BMD were explained by age strongly affecting both exposure and BMD. Moreover, neither CTX, which reflects osteoclastic activity, nor osteocalcin, which reflects osteoblastic activity, were associated with any of the POC exposure markers.
It is always important in cross-sectional studies to be aware of potential selection bias. A comparison between the participants and subjects who were invited but in the end not included showed no obvious differences with risk factors for osteoporosis such as age, BMI, history of osteoporotic fractures, or smoking habits. We therefore do not believe selection bias is of major concern in the present study. For the POC biomarkers CB-153 and p,p'-DDE, and for U-Cd, the analytic accuracies and precisions were good. The long biological half-lives of many years for CB-153 and p,p'-DDE mean that current serum levels well reflect POC exposure for the years preceding the cross-sectional study. Thus, we have a good measure of exposure for the period when bone metabolism could have been affected. Therefore, we do not consider misclassification of exposure to be an important bias in the present study.
We chose to use the DTX-200 for measuring distal forearm BMD partly because the equipment had to be portable and stable after transport. Moreover, distal forearm BMD is a relevant measure for risk for osteo- Table 4 The effect of CB-153 and p,p'-DDE, respectively, on bone mineral density (BMD) among 184 fishermen's wives from the Swedish east coast obtained from linear regression models. The exposure variables were treated as continuous [ porosis. In a recent meta-analysis it was shown that BMD, irrespective of the measurement site, predicts the occurrence of osteoporotic fractures [51] . The analytical accuracies and precisions of the biochemical bone markers were good. We excluded subjects with known very strong risk factors for osteoporosis (high PTH values, Cushing's disease, and long-term treatment with oral steroids) to avoid weak associations between the exposure variables and the outcome variables being overshadowed by these factors.
A thorough and systematic analysis of the effect of including a number of potential confounders in the multivariate models showed that only age and BMI were Fig. 1 The association between serum concentrations of 2,2',4,4',5,5'-hexachlorobiphenyl (CB-153) and bone mineral density among 196 fishermen from the Swedish east coast off the Baltic Sea Fig. 2 The association between serum concentrations of 2,2',4,4',5,5'-hexachlorobiphenyl (CB-153) and bone mineral density among 184 fishermen's wives from the Swedish east coast off the Baltic Sea of importance for assessing the impact of the POC exposure variables. Whether the association between POC and BMI should be expected to be positive or negative is dependent on the timing of blood sampling in relation to the period when more substantial dietary POC exposure had taken place [52] . If this exposure had been recent, subjects with high BMI (those with large adipose distribution volumes) should be expected to have a negative association between BMI and lipid-adjusted POP levels in serum. On the other hand, if the blood samples, as in the present study, were drawn many years after the end of a more substantial exposure than the current one, and the subjects were old enough to have reached a steady state of their body burdens of POC considering the long biological half-lives of many of these compounds, a positive association between BMI and POC in serum could be expected. Thus, it was a reasonable finding that the association between CB-153 and BMD became slightly weaker when adjusting for BMI.
The main reason for analyzing U-Cd in the present study was the need to exclude any potential confounding effect on associations between POC exposure and BMD and bone metabolism markers. However, when assessing the effect of U-Cd we did not observe significant associations with any of the outcome variables. High Cd exposure will damage the kidneys, followed by severe osteoporosis and osteomalacia as a secondary effect [29, 30] . A slightly alarming finding has been that recent European studies have suggested that Cd can induce osteoporosis at much lower exposure levels than previously reported [31] [32] [33] . We could, however, not corroborate those results. A reason for this discrepancy might be that in the present study the average U-Cd level was lower and the exposure range was much narrower than in the previous ones, hampering evaluation of exposure-response associations.
In animal studies, POCs have impaired normal bone metabolism, resulting in increased bone fragility [1] [2] [3] [4] . Dioxin was shown to inhibit tibial growth in rats in a dose-dependent way [3] . Moreover, a dioxin-like PCBcongener impaired the mineralization process of tibiae in rats [1] and also reduced the collagen content and serum osteocalcin levels, which resulted in impaired maximum torque and stiffness of the rat humerus [2] . Further, the trabecular bone density in the Baltic grey seal was lower during the period of maximum POC contamination in the Baltic Sea than during both a preceding period and the later period [53] . Thus, data are accumulating that support the idea that POC may interfere with normal bone metabolism, but the mechanisms are not yet fully understood, nor whether these effects may also occur after exposure to nondioxin-like POCs.
The results from previous epidemiology are rather ambiguous. In a Swedish study of 115 middle-aged and elderly men from the general population, a number of different POC were analyzed in serum, but it was only p,p'-DDE that showed a slight negative association with BMD in the multivariate models [34] . The exposure levels were slightly lower than for the men in the present study. Among 68 Australian middle-aged sedentary women, there remained a weak negative association between p,p'-DDE and BMD, even after adjustment for age and HRT [35] . The exposure levels for the Australian women were almost as high as for the women in the present study. Finally, in a study from the United States of 103 middle-aged women with repeated measurements of BMD performed in the 1980s, no associations between BMD and serum levels of p,p'-DDE were observed after adjustment for confounders [36] . These American women had, on the average, been about twice as highly exposed for p,p'-DDE as the women in the present study.
It is noteworthy that the present study is the first epidemiological assessment of the impact of POC not only on BMD but also on biochemical markers of bone metabolism. Our findings were completely negative. However, these results ought to be evaluated in studies including even larger study samples and in longitudinal studies. Another aspect to consider is that even though we could not see any effect on radial BMD and the bone turnover markers, other mechanical properties of bone (such as bone size and quality) could be affected by POCs.
The results of the present study should also be considered in relation to the results from our studies on osteoporotic fracture incidence in Swedish fishermen's families, from which the present study group was recruited. In a register-based study there was a significantly increased incidence rate ratio (IRR 2.29, 95% CI 1.23-4.28) for vertebral fractures among fishermen's wives from the Swedish east coast off the Baltic Sea where the fish was much more polluted with POC compared with the Swedish west coast [41] . Such cohort differences were not seen for any other fracture type. In a questionnaire study there were no differences in fracture incidence between fishermen or fishermen's wives from the east and west coasts, respectively [42] . However, east coast fishermen's wives with more than one meal of fatty fish from the Baltic Sea per month had an increased incidence of osteoporotic fractures compared with east coast wives who ate at most one such meal per month (age-adjusted IRR 1.68, 95% CI 1.00-2.84). No such exposure-response association was seen among the fishermen. Taken together, the fracture incidence studies were not very consistent with respect to an association between estimated POC exposure and enhanced risk for osteoporotic fractures. However, a caveat with this conclusion is that the fracture incidence studies performed so far have mainly ascertained symptomatic fractures, which constitute only a small fraction of vertebral fractures. An x-ray-based study might provide more conclusive results.
The fishermen and their wives comprising our study base were considerably more highly exposed to POC than the general Swedish population [38] [39] [40] . Thus, adding the results from the present cross-sectional study of BMD and bone metabolism with the results from the fracture incidence studies in the same study base [41, 42] does not provide any support for the hypothesis that the current exposure levels to POC constitute a hazard for impaired bone metabolism and fractures in the general Swedish population. There is, however, a need for complementary large-scale epidemiological studies, including longitudinal follow-up of BMD and x-ray studies of fractures in relation to POC exposure, before a more definite conclusion can be drawn.
